Absolute quantification of endogenous angiotensin II levels in human plasma using ESI-LC-MS/MS

Clinical Proteomics

Volumn 11, Issue 1, 2014, Pages

  Schulz, Anna ^a   Jankowski, Joachim ^a   Zidek, Walter ^b   Jankowski, Vera ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN II ANTIBODY; CARBON 13; NITROGEN 15;

ACCURACY; ANALYTIC METHOD; ANGIOTENSIN BLOOD LEVEL; ANION EXCHANGE CHROMATOGRAPHY; ANTIBODY AFFINITY; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACTION CARTRIDGE; FRACTIONATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE DETERMINATION; HUMAN; INTERMETHOD COMPARISON; ISOTOPE LABELING; LABORATORY DEVICE; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; PERFORMANCE MEASUREMENT SYSTEM; PROTEIN IMMOBILIZATION; PROTEIN PURIFICATION; QUALITY CONTROL; QUANTITATIVE STUDY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; STANDARD; TANDEM MASS SPECTROMETRY;

EID: 84920449786     PISSN: 15426416     EISSN: 15590275     Source Type: Journal    
DOI: 10.1186/1559-0275-11-37     Document Type: Article

References (16)

1. Zhuo JL, Ferrao FM, Zheng Y, Li XC: New frontiers in the intrarenal renin-angiotensin system: a critical review of classical and new paradigms. Front Endocri (Lausanne) 2013, 4:166.
2. Braun-Menendez E, Fasciolo JC, Leloir LF, Muñoz JM: The substance causing renal hypertension. J Physiol 1940,98(3):283-298.
3. Wolf G, Butzmann U, Wenzel UO: The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology. Nephron Physiol 2003,93(1):3-13. 10.1159/000066656
4. Siamopoulos KC, Kalaitzidis RG: Inhibition of the renin-angiotensin system and chronic kidney disease. Int Urol Nephrol 2008,40(4):1015-1025. 10.1007/s11255-008-9424-x
5. Rodriguez-Iturbe B, Garcia Garcia G: The role of tubulointerstitial inflammation in the progression of chronic renal failure. Nephron Clin Pract 2010,116(2):c81-c88. 10.1159/000314656
6. Jankowski V, Vanholder R, van der Giet M, Tölle M, Karadogan S, Gobom J, Furkert J, Oksche A, Krause E, Tran TN, Tepel M, Schuchardt M, Schlüter H, Wiedon A, Beyermann M, Bader M, Todiras M, Zidek W, Jankowski J: Mass-spectrometric identification of a novel angiotensin peptide in human plasma. Arterioscler Thromb Vasc Biol 2007,27(2):297-302.
7. Jankowski V, Tölle M, Santos RA, Günthner T, Krause E, Beyermann M, Welker P, Bader M, Pinheiro SV, Sampaio WO, Lautner R, Kretschmer A, van der Giet M, Zidek W, Jankowski J: Angioprotectin: an angiotensin II-like peptide causing vasodilatory effects. FASEB J 2011,25(9):2987-2995. 10.1096/fj.11-185470
8. Grzybowski J, Bilińska ZT, Janas J, Michalak E, Skwarek M, Ruzyłło W: Level of angiotensin II and aldosterone in plasma is often elevated in patients with heart failure treated with converting enzyme inhibitors-preliminary results. Przegl Lek 2002,59(8):587-589.
9. Hermann K, von Eschenbach CE, von Tschirschnitz M, Ring J: Plasma concentrations of arginine vasopressin, oxytocin and angiotensin in patients with hymenoptera venom anaphylaxis. Regul Pept 1993,49(1):1-7. 10.1016/0167-0115(93)90377-K
10. Shimamoto K, Nakagawa M, Iimura O: In vivo concentrations of kinins and angiotensins. Horm Metab Res Suppl 1990, 22:75-79. 10.1055/s-2007-1004855
11. Sim MK, Qui XS: Angiotensins in plasma of hypertensive rats and human. Regul Pept 2003,111(1-3):179-182.
12. Huang W, Yang Y, Wu S, Jin Z, Bao D, Gan H: Early changes of arginine vasopressin and angiotensin II in patients with acute cerebral injury. Chin J Traumatol 2001,4(3):161-163.
13. Brun V, Masselon C, Garin J, Dupuis A: Isotope dilution strategies for absolute quantitative proteomics. J Proteomics 2009,72(5):740-749. 10.1016/j.jprot.2009.03.007
14. Sturm R, Sheynkman G, Booth C, Smith LM, Pedersen JA, Li L: Absolute quantification of prion protein (90-231) using stable isotope-labeled chymotryptic peptide standards in a LC-MRM AQUA workflow. J Am Soc Mass Spectrom 2012,23(9):1522-1533. 10.1007/s13361-012-0411-1
15. Chambers EE, Fountain KJ, Smith N, Ashraf L, Karalliedde J, Cowan D, Legido-Quigley C: Multidimensional LC-MS/MS enables simultaneous quantification of intact human insulin and five recombinant analogs in human plasma. Anal Chem 2014, 86:694-702. 10.1021/ac403055d
16. Thomas A, Geyer H, Kamber M, Schänzer W, Thevis M: Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS. J Mass Spectrom 2008, 43:908-915. 10.1002/jms.1453